Cessatech is a Danish company active in the pharmaceutical industry. The company specializes in the research and development of analgesic nasal spray that is further used for the treatment of acute pain conditions among children. In addition to the main business, service and associated ancillary services are also offered. The business is run globally with the largest presence in the Nordic market.

Quotes for Cessatech A/S

Right Now

+/-
0.64
%
11,03%
Latest
6.44
High
6.5
Low
6.2
Volume
4 083
Turnover (DKK)
26 425
Market Value (MDKK)
39,4
Time (Latest trade)
2022-07-01 13:31

Board

CEO

  • Jes Trygved

Chairperson of the Board

  • Adam Steensberg

Board

  • Charlotte Videbæk
  • Flemming Steen Jensen
  • Martin Olin
  • Peter Birk

Largest Owners

Name Capital % Votes % Date
Steen Winther Henneberg 13,59 13,59 2020-12-16
Bettina Nygaard Nielsen 13,59 13,59 2020-12-16
Jes Trygved 9,27 9,27 2021-12-08
Buhl Krone Holding ApS 8,82 8,82 2021-12-08
C-Aps 1,12 1,12 2021-12-08
Martin Olin 1,09 1,09 2021-12-08
Adam Steensberg 0,74 0,74 2021-12-08
Peter Birk 0,17 0,17 2021-12-08
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-08-19 Delårsrapport 2022-Q2

  • 2022-11-18 Delårsrapport 2022-Q3

  • 2023-03-03 Bokslutskommuniké 2022